The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background
In patients with chronic obstructive pulmonary disease (COPD) and co‐morbid cardiovascular disease, emerging evidence suggests a benefit in commencing cardioselective beta‐blockers.
Aim
Our objective was to determine the safety of beta‐blocker commencement during hospitalisation for acute exacerbation of COPD.
Methods
A retrospective cohort study of 1071 patients hospitalised for acute...
The use of beta‐blockers in patients with chronic obstructive pulmonary disease and co‐morbid cardiovascular disease is controversial, despite increasing evidence to support their use as safe and efficacious. This study retrospectively assessed the rates of beta‐blocker prescription in patients admitted to two Australian tertiary hospitals for acute exacerbation of chronic obstructive pulmonary disease...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.